We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $960M
1-Year Est. Return 79.37%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+79.37%
3 Year Est. Return
+262.34%
5 Year Est. Return
+412.53%
10 Year Est. Return
+2,309.54%
AUM
$663M
AUM Growth
+$148K
Cap. Flow
+$14.7M
Cap. Flow %
2.22%
Top 10 Hldgs %
19.93%
Holding
348
New
50
Increased
146
Reduced
80
Closed
39

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$13.9M
2
DOCU
DocuSign
DOCU
+$9.5M
3
FXN icon
First Trust Energy AlphaDEX Fund
FXN
+$8.09M
4
ZM icon
Zoom
ZM
+$7.29M
5
GPC icon
Genuine Parts
GPC
+$6.62M

Sector Composition

Rank Sector Weight
1 Technology 27.93%
2 Healthcare 16.83%
3 Industrials 16.17%
4 Consumer Discretionary 11.55%
5 Consumer Staples 4.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.86T
$27.5M 4.15%
1,329,310
+92,630
+7% +$1.92M
WST icon
2
West Pharmaceutical
WST
$24B
$18.1M 2.73%
42,667
+19,972
+88% +$8.42M
EPAM icon
3
EPAM Systems
EPAM
$5.51B
$12.2M 1.83%
21,318
+298
+1% +$175K
GNRC icon
4
Generac Holdings
GNRC
$11.6B
$11.5M 1.74%
28,211
+3,692
+15% +$1.58M
JCI icon
5
Johnson Controls International
JCI
$88.8B
$11.2M 1.7%
165,173
+3,048
+2% +$220K
TT icon
6
Trane Technologies
TT
$100B
$11.2M 1.68%
64,724
+933
+1% +$179K
AMN icon
7
AMN Healthcare
AMN
$1.3B
$11.2M 1.68%
97,285
+690
+0.7% +$73.2K
IDXX icon
8
Idexx Laboratories
IDXX
$44.1B
$10.5M 1.58%
16,901
-7
-0% -$4.7K
TECH icon
9
Bio-Techne
TECH
$11.2B
$9.98M 1.5%
82,368
+16
+0% +$1.95K
FTNT icon
10
Fortinet
FTNT
$119B
$8.79M 1.33%
150,465
-1,120
-0.7% -$64.8K
UMC icon
11
United Microelectronic
UMC
$47.7B
$8.79M 1.32%
768,690
+33,368
+5% +$358K
ENTG icon
12
Entegris
ENTG
$18.1B
$8.41M 1.27%
66,832
+52
+0.1% +$6.27K
ENPH icon
13
Enphase Energy
ENPH
$4.96B
$8.26M 1.25%
55,083
+1,493
+3% +$256K
TEAM icon
14
Atlassian
TEAM
$25.6B
$8.13M 1.23%
20,757
+2,978
+17% +$995K
APPS icon
15
Digital Turbine
APPS
$975M
$8.06M 1.21%
117,196
+11,797
+11% +$732K
INTU icon
16
Intuit
INTU
$86.5B
$7.72M 1.16%
+14,313
New +$7.71M
CRWD icon
17
CrowdStrike
CRWD
$194B
$7.66M 1.15%
124,636
+8,156
+7% +$526K
XYL icon
18
Xylem
XYL
$27.3B
$7.63M 1.15%
+61,661
New +$7.94M
TGT icon
19
Target
TGT
$65.6B
$7.58M 1.14%
33,115
+5,988
+22% +$1.5M
OMCL icon
20
Omnicell
OMCL
$1.61B
$7.44M 1.12%
+50,107
New +$7.68M
IP icon
21
International Paper
IP
$21.6B
$7.37M 1.11%
139,218
+432
+0.3% +$24K
QTEC icon
22
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.52B
$7.34M 1.11%
+46,536
New +$7.56M
FXH icon
23
First Trust Health Care AlphaDEX Fund
FXH
$1.04B
$7.25M 1.09%
60,880
-5,995
-9% -$734K
FXO icon
24
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$7.22M 1.09%
163,201
-7,564
-4% -$335K
FXG icon
25
First Trust Consumer Staples AlphaDEX Fund
FXG
$229M
$7.16M 1.08%
127,122
+4,411
+4% +$250K

Similar funds

Navellier & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Navellier & Associates held 348 positions worth $663M, up 0.02% from $663M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Navellier & Associates's Q3 2021 filing shows 50 new, 146 increased, 80 reduced and 39 closed positions. Its largest new stake was Xylem: 61,661 shares worth $7.63M. The largest sale was PayPal, an estimated $13.9M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Navellier & Associates's largest Q3 2021 buy was Xylem: 61,661 shares worth $7.63M.
  • Navellier & Associates added most to West Pharmaceutical in Q3 2021, an estimated $8.42M increase.
  • Navellier & Associates's biggest Q3 2021 reduction was Genuine Parts, cutting an estimated $6.62M.
  • Navellier & Associates fully exited PayPal in Q3 2021, selling an estimated $13.9M.
  • Navellier & Associates's ten largest holdings make up 20% of its $663M portfolio in Q3 2021.
  • Navellier & Associates opened 50 new positions and closed 39 in Q3 2021.
  • Navellier & Associates's portfolio value rose 0.02% quarter-over-quarter to $663M.

Based on Navellier & Associates's 13F filing for Q3 2021, filed 28 Oct 2021.